Home
Obi Profile
Fees
Services
News
Publications
Contact
You are here:
Title Details
Search
Login
USE OF A TYPE II ANTI-CD20 ANTIBODY WITH INCREASED ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY (ADCC) IN COMBINATION WITH CYCLOPHOSPHAMIDE, VINCRISTINE AND DOXORUBICINE FOR TREATING NON-HODGKIN' S LYMPHOMAS
No-Receipt date
2016-02860 - 07/09/2016
No-Filing date
20160402152 - 07/09/2016
No-Granting date
3089956 - 25/10/2016
No-EPO application date
09723808.3 - 23/03/2009
No-EPO granting date
2268310 - 20/07/2016
Gazette No-Publication date of application
-
Gazette No-Publication date of granted patent
10/2016 - 18/11/2016
Expiration date
24/03/2029
Kind of title
Validation of European Patent
Legal status
VALID
Priorities
EP0800555425/03/2008/EP
EP0800717211/04/2008/EP
Active Substance of Supplementary Certificates
-
IPC Classification
Ipc Class
A61K 39/395
A61P 35/00
C07K 16/28
Related Documents
Related Titles
Owners
Code
Firstname
Surname
Address
Town
ZIP
Country
701041
ROCHE GLYCART AG
WAGISTRASSE 18
8952 SCHLIEREN-ZUERICH
SWITZERLAND
Inventors
Code
Firstname
Surname
1714484
DUMONTET, CHARLES
1714485
FRIESS, THOMAS
1714486
HERTING, FRANK
1714487
KLEIN, CHRISTIAN
1714488
UMANA, PABLO
Representatives
Code
Firstname
Surname
Address
Town
Zip
3190
KONSTANTINOS
KILIMIRIS "PATRINOS & KILIMIRIS DIKIGORIKI ETAIRIA"
CHATZIGIANNI MEXI 7
ATHINA (ATTIKIS)
11528
Contact
Code
Firstname
Surname
Address
Town
Zip
Country
8149
KONSTANTINOS
KILIMIRIS
CHATZIGIANNI MEXI 7
ATHINA (ATTIKIS)
11528
GREECE
Owners History
Title Instruments
Date
Operation
Descreption
9/10/2020 12:00:00 AM
Διάφορες Μεταβολές (70004)
ΑΡΣΗ & ΑΝΤΙΚ/ΣΤΑΣΗ ΠΛΗΡΕΞ.-ΑΝΤΙΚΛΗΤΟΥ
Payments history
17 renewals have been done
© OBI all rights reserved
designed & developed by PROFILE S.A.
Certified QMS :
EN ISO 9001:2015
and
ΕΝ ISO 14001:2015
The project "Internet technological information diffusion from industrial property titles" is co-financed 70% by the European Regional Development Found and 30% by the Hellenic public sector (Operational programme "Competitiveness", Measure 4.4).